Trump's Pharma Deal Aims to Lower US Prescription Costs
President Trump announces a 'Most Favored Nations' pricing pact with nine major drug firms, promising lower costs for Americans and $150bn in US investment. Read the full details.
Category : Search result: Trump pharmaceutical deal
Nine more drug firms join Trump's price-cutting scheme
President Trump announces nine major pharmaceutical companies have agreed to slash US prescription prices to match cheaper international rates. The 'Trump Rx' website launches next month.
Lutnick grilled over Trump's 'impossible' 600% drug price claim
Commerce Secretary Howard Lutnick was pressed by Fox News to explain President Trump's claim of cutting drug prices by up to 600%, a figure experts call mathematically impossible. Read the full fact-check here.
Trump criticised for 'basic maths' error in drug price claim
Donald Trump faces ridicule after claiming he slashed pharmaceutical prices by '600%' in a White House speech. Critics highlight the mathematical impossibility of the statement. Read the full story.
UK-US Pharma Deal Lacks Legal Text, MPs Warn
MPs warn UK's zero-tariff pharmaceutical deal with the Trump administration is 'built on sand' as no legal text exists. Concerns mount over NHS costs and suspended tech pact. Read the full analysis.
NHS to pay £1bn more for drugs under US trade deal
The NHS must find an extra £1bn annually for medicines under a new US trade pact, with no new Treasury funding. Health leaders warn of frontline service cuts. Read the full analysis.
NHS Trump drug deal 'may cost 15,000 lives'
A £3bn deal to pay US drug firms more and avoid Trump's tariffs could lead to 15,971 extra deaths yearly as NHS rations care, York University research reveals. Read the full analysis.
UK-US Agree Zero Tariff Deal on Medicines
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
UK-US strike tariff deal on pharmaceuticals
The UK and US agree a major trade deal removing US import taxes on UK drugs for 3 years, while the NHS commits to higher spending on new medicines. Discover the impact.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
UK-US Agree Zero-Tariff Pharmaceuticals Deal
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
NHS drug costs to rise 25% in US trade deal
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
UK and US agree zero tariff deal on medicines
The UK and US have agreed a three-year deal to maintain 0% import tariffs on pharmaceuticals, aiming to secure NHS access to cutting-edge treatments and boost investment. Read the full details.
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
Ukraine agrees to Trump-brokered peace deal
A US official claims Ukraine has agreed to a peace deal brokered by Donald Trump, with only minor details left to finalise. Follow for the latest breaking news.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Trump's Weight Loss Sparks Pharmaceutical Frenzy
Donald Trump's dramatic weight loss sparks pharmaceutical frenzy as Novo Nordisk faces unprecedented demand for revolutionary diabetes medications.
Trump slams 'fat shot' weight loss drugs in explosive rant
Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
Trump's plan to slash weight-loss drug prices
Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.
Trump pledges to cut weight-loss drug prices
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
Trump Pressures Novo Nordisk Over Ozempic Pricing
Former President Donald Trump is reportedly pushing pharmaceutical giant Novo Nordisk for major Ozempic price cuts in a move that could transform diabetes and weight loss treatment accessibility in America.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
Page 1 of 4